Cardiovascular Systems (NSDQ:CSII) this week announced that it has partnered with Innova Vascular to develop a full line of thrombectomy devices.
Under the terms of the agreement, Cardiovascular Systems will provide financing to Innova for the development of thrombectomy devices to remove blood clots from arteries and veins. Through an acquisition option agreement, Cardiovascular Systems will have exclusive rights to acquire the devices upon Innova’s completion of key technical, regulatory and clinical milestones.
Get the full story on our sister site, Medical Tubing + Extrusion.